latest from linkedin
March 2025
New Publication: Advancing UTI Diagnostics
We are thrilled to share our latest research on Urinary Tract Infections (UTIs), a condition affecting over 400 million people annually and a leading cause of empiric antibiotic prescriptions by GPs. Our study highlights how miniaturised chromogenic bacterial cultivation and rapid antimicrobial susceptibility testing (RAST) can be integrated into cost-effective, easy-to-use dipsticks for point-of-care (POC) diagnostics.
This breakthrough enables faster, more targeted treatments, supports global antimicrobial resistance (AMR) initiatives, and aligns with WHO goals. Designed for accessibility in general practice, the technology is also scalable for low- and middle-income countries (LMICs) and fully compliant with IVDR and professional guidelines.
🔗 Read the full study here: https://pubmed.ncbi.nlm.nih.gov/40063324/ Iseri E, Jakobsson G, Bertling S, Özenci V, Ekelund O, van der Wijngaart W, van Belkum A. Rapid diagnosis of urinary tract infection with miniaturised point-of-care cultivation on a dipstick. Eur J Clin Microbiol Infect Dis. 2025 Mar 10. doi: 10.1007/s10096-025-05088-7. Epub ahead of print. PMID: 40063324.
Together, we can bring innovation closer to patients and combat antimicrobial resistance.
October 2024
Meet us at MEDICA trade fair in Düsseldorf on 11-14 November 2024 where we’re looking forward to meeting potential distributors and partners. To pre-book your meeting with Utilizer Founder & CEO Sofia Bertling or Director of Marketing & Sales Gabriella von Flittner please get in touch prior to the event.
January 2024
We are growing! Welcome Karin Andersson, we are proud to have you onboard! Karin joins as chairwoman of the board, bringing with her extensive strategic company experience based in Marketing & MedTech.
November 2023
Welcome Shanila Mazid! Shanila joins our team as Director of Manufacturing, bringing with her extensive MedTech and scaled manufacturing experience. She will lead UTI-lizer’s journey towards scaled manufacturing.
October 2024
Please join us in extending a warm welcome to our newest team member; Gino Jakobsson a medical doctor with 5 years of experience as a healthcare professional including business development in the hospital setting and has an entrepreneurial background. He will join the team as Medical Affairs Liaison and have an important role in the journey ahead.
September 2023
We are exhibiting at Linus Dagarna together with EMM Life Science AB Växjö, 19-21 September 2023.
May 2023
We closed our first investment round and raised 7M SEK! The investors include ALMI Invest, together with life science angel investors and the Propel Capital. More information can be found in our press releases available in English and Swedish.
September 2023
We presented results of our clinical performance study at Karolinska University Hospital at ECCMID (European Society of Clinical Microbiology and Infectious Diseases) 2023.
September 2022
22 new companies of Sting are announced in Dagens Industri and Utilizer is one of them!
June 2022
We got support from Vinnova! Our preparatory project for international proposal is accepted. We will be setting a multi-center clinical trial for our tests at the point-of-care.
June 2022
We successfully completed first extensive clinical validation and performance study of our tests at the Karolinska University Hospital! Read more…
May 2022
Utilizer has joined the leading Nordic incubator Sting!
September 2021
Utillizer has been selected as one of the Hello Tomorrow Deep Tech Pioneers!
July 2020
Utilizer got the EIT Health Wildcard! We have participated in EIT Health Wildcard Hackathon.